The cancer nuclear microenvironment: Interface between light microscopic cytology and molecular phenotype

Journal of Cellular Biochemistry

Volumn 104, Issue 6, 2008, Pages 1994-2003

  True, Lawrence D ^a,b   Jordan, C Diana ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

^b UNIVERSITY OF WASHINGTON MEDICAL CENTER   (United States)

Author keywords

Cancer; Chromatin; Cytology; Matrix; Nucleus

Indexed keywords

CARCINOMA CELL; CELL NUCLEUS; CELL STRUCTURE; CELL TYPE; COILED BODY; CONFERENCE PAPER; CYTOLOGY; ELECTRON MICROSCOPY; HETEROCHROMATIN; HUMAN; LIGHT MICROSCOPIC CYTOLOGY; MICROSCOPY; MORPHOMETRICS; NEUROSECRETORY CELL; NEUTROPHIL; NUCLEOLUS; PHENOTYPE; PRIORITY JOURNAL; PROGNOSIS; STROMA CELL;

CELL NUCLEUS; CELL NUCLEUS SHAPE; CELL NUCLEUS STRUCTURES; HUMANS; MICROSCOPY; NEOPLASMS; PHENOTYPE;

EID: 49049117524     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.21478     Document Type: Conference Paper

References (52)

1. Baak JPA. 1991. Manual of quantitative pathology in cancer diagnosis and prognosis. Berlin, Germany: Springer-Verlag.
2. Bartova E, Kozubek S, Jirsova P, Kozubek M, Lukasova E, Skalnikova M, Cafourkova A, Koutna I, Pasekova R. 2001. Higher-order chromatin structure of human granulocytes. Chromosoma 110:360-370.
3. Becker M, Baumann C, John S, Walker DA, Vigneron M, McNally JG, Hager GL. 2002. Dynamic behavior of transcription factors on a natural promoter in living cells. EMBO Rep 3:1188-1194.
4. Bibbo M, Bartels PH, Sychra JJ, Wied GL. 1981. Chromatin appearance in intermediate cells from patients with uterine cancer. Acta Cytol 25:23-28.
5. Boisvert FM, Kruhlak MJ, Box AK, Hendzel MJ, Bazett-Jones DP. 2001. The transcription coactivator CBP is a dynamic component of the promyelocytic leukemia nuclear body. J Cell Biol 152:1099-1106.
6. Capelson M, Corces VG. 2004. Boundary elements and nuclear organization. Biol Cell 96:617-629.
7. Clemson CM, Hall LL, Byron M, McNeil J, Lawrence JB. 2006. The X chromosome is organized into a gene-rich outer rim and an internal core containing silenced non-genic sequences. Proc Natl Acad Sci USA 103:7688-7693.
8. Collan Y, Torkkeli T, Kosma VM, Pesonen E, Kosunen O, Jantunen E, Mariuzzi GM, Montironi R, Marinelli F, Collina G. 1987a. Sampling in diagnostic morphometry: The influence of variation sources. Pathol Res Pract 182:401-406.
9. Collan Y, Torkkeli T, Pesonen E, Jantunen E, Kosma VM. 1987b. Application of morphometry in tumor pathology. Anal Quant Cytol Histol 9:79-88.
10. Cremer T, Kupper K, Dietzel S, Fakan S. 2004. Higher order chromatin architecture in the cell nucleus: On the way from structure to function. Biol Cell 96:555-567.
11. Demay RM. 1999. Practical principles of cytopathology. Chicago, IL,USA: American Society of Clinical Pathology.
12. Doudkine A, Macaulay C, Poulin N, Palcic B. 1995. Nuclear texture measurements in image cytometry. Pathologica 87:286-299.
13. Epstein JI, Berry SJ, Eggleston JC. 1984. Nuclear roundness factor. A predictor of progression in untreated Stage A2 prostate cancer. Cancer 54:1666-1671.
14. Frey MR, Matera AG. 2001. RNA-mediated interaction of Cajal bodies and U2 snRNA genes. J Cell Biol 154:499-509.
15. Fung LC, De Boni U. 1988. Modulation of nuclear rotation in neuronal interphase nuclei by nerve growth factor, by gamma-aminobutyric acid, and by changes in intracellular calcium. Cell Motil Cytoskeleton 10:363-373.
16. Getzenberg RH, Konety BR, Oeler TA, Quigley MM, Hakam A, Becich MJ, Bahnson RR. 1996. Bladder cancer-associated nuclear matrix proteins. Cancer Res 56:1690-1694.
17. Gilbert N, Boyle S, Fiegler H, Woodfine K, Carter NP, Bickmore WA. 2004. Chromatin architecture of the human genome: Gene-rich domains are enriched in open chromatin fibers. Cell 118:555-566.
18. Grummt I. 2006. Actin and myosin as transcription factors. Curr Opin Genet Dev 16:191-196.
19. Guillaud M, Adler-Storthz K, Malpica A, Staerkel G, Matisic J, Van Niekirk D, Cox D, Poulin N, Follen M, Macaulay C. 2005. Subvisual chromatin changes in cervical epithelium measured by texture image analysis and correlated with HPV. Gynecol Oncol 99:S16-S23.
20. Hancock R. 2004. Internal organisation of the nucleus: Assembly of compartments by macromolecular crowding and the nuclear matrix model. Biol Cell 96:595-601.
21. Helpap B. 1988. Observations on the number, size and localization of nucleoli in hyperplastic and neoplastic prostatic disease. Histopathology 13:203-211.
22. Huisman A, Ploeger LS, Dullens HF, Poulin N, Grizzle WE, van Diest PJ. 2005. Development of 3D chromatin texture analysis using confocal laser scanning microscopy. Cell Oncol 27:335-345.
23. Huisman A, Ploeger LS, Dullens HF, Jonges TN, Belien JA, Meijer GA, Poulin N, Grizzle WE, van Diest PJ. 2007. Discrimination between benign and malignant prostate tissue using chromatin texture analysis in 3-D by confocal laser scanning microscopy. Prostate 67:248-254.
24. Kosak ST, Groudine M. 2004. Form follows function: The genomic organization of cellular differentiation. Genes Dev 18:1371-1384.
25. Lamond AI, Spector DL. 2003. Nuclear speckles: A model for nuclear organelles. Nat Rev Mol Cell Biol 4:605-612.
26. Liautaud-Roger F, Teyssier JR, Ferre D, Dufer J, Coninx P. 1992. Can chromatin texture predict structural karyotype changes in diploid cells from thyroid cold nodules? Anal Cell Pathol 4:421-428.
27. Mairinger T, Mikuz G, Gschwendtner A. 1999. Nuclear chromatin texture analysis of nonmalignant tissue can detect adjacent prostatic adenocarcinoma. Prostate 41:12-19.
28. Mandelbrot BB. 1975. Stochastic models for the Earth's relief, the shape and the fractal dimension of the coastlines, and the number-area rule for islands. Proc Natl Acad Sci USA 72:3825-3828.
29. Martelli AM, Falcieri E, Zweyer M, Bortul R, Tabellini G, Cappellini A, Cocco L, Manzoli L. 2002. The controversial nuclear matrix: A balanced point of view. Histol Histopathol 17:1193-1205.
30. Meaburn KJ, Misteli T, Soutoglou E. 2007. Spatial genome organization in the formation of chromosomal translocations. Semin Cancer Biol 17:80-90.
31. Misteli T. 2007. Beyond the sequence: Cellular organization of genome function. Cell 128:787-800.
32. Mohler JL, Figlesthaler WM, Zhang XZ, Partin AW, Maygarden SJ. 1994a. Nuclear shape analysis for the assessment of local invasion and metastases in clinically localized prostate carcinoma. Cancer 74:2996-3001.
33. Mohler JL, Metts JC, Zhang XZ, Maygarden SJ. 1994b. Nuclear morphometry in automatic biopsy and radical prostatectomy specimens of prostatic carcinoma. A comparison. Anal Quant Cytol Histol 16:415-420.
34. Mulder JW, Offerhaus GJ, de Feyter EP, Floyd JJ, Kern SE, Vogelstein B, Hamilton SR. 1992. The relationship of quantitative nuclear morphology to molecular genetic alterations in the adenoma-carcinoma sequence of the large bowel. Am J Pathol 141:797-804.
35. Nickerson JA. 1998. Nuclear dreams: The malignant alteration of nuclear architecture. J Cell Biochem 70:172-180.
36. Olins AL, Olins DE. 2004. Cytoskeletal influences on nuclear shape in granulocytic HL-60 cells. BMC Cell Biol 5:30.
37. Pageau GJ, Hall LL, Lawrence JB. 2007. BRCA1 does not paint the inactive X to localize XIST RNA but may contribute to broad changes in cancer that impact XIST and Xi heterochromatin. J Cell Biochem 100:835-850.
38. Pederson T. 2000. Half a century of "the nuclear matrix". Mol Biol Cell 11:799-805.
39. Pederson T, Aebi U. 2005. Nuclear actin extends, with no contraction in sight. Mol Biol Cell 16:5055-5060.
40. Penman S. 1995. Rethinking cell structure. Proc Natl Acad Sci USA 92:5251-5257.
41. Percipalle P, Farrants AK. 2006. Chromatin remodelling and transcription: Be-WICHed by nuclear myosin 1. Curr Opin Cell Biol 18:267-274.
42. Phair RD, Scaffidi P, Elbi C, Vecerova J, Dey A, Ozato K, Brown DT, Hager G, Bustin M, Misteli T. 2004. Global nature of dynamic protein-chromatin interactions in vivo: Three-dimensional genome scanning and dynamic interaction networks of chromatin proteins. Mol Cell Biol 24:6393-6402.
43. Poulin N, Frost A, Carraro A, Mommers E, Guillaud M, Van Diest PJ, Grizzle W, Beenken S. 2003. Risk biomarker assessment for breast cancer progression: Replication precision of nuclear morphometry. Anal Cell Pathol 25:129-138.
44. Rivera OJ, Song CS, Centonze VE, Lechleiter JD, Chatterjee B, Roy AK. 2003. Role of the promyelocytic leukemia body in the dynamic interaction between the androgen receptor and steroid receptor coactivator-1 in living cells. Mol Endocrinol 17:128-140.
45. Sadi MV, Barrack ER. 1993. Image analysis of androgen receptor immunostaining in metastatic prostate cancer. Heterogeneity as a predictor of response to hormonal therapy. Cancer 71:2574-2580.
46. Schmid K, Angerstein N, Geleff S, Gschwendtner A. 2006. Quantitative nuclear texture features analysis confirms WHO classification 2004 for lung carcinomas. Mod Pathol 19:453-459.
47. Shoji M, Dobashi Y, Morinaga S, Jiang SX, Kameya T. 1999. Tumor extension and cell proliferation in adenocarcinomas of the lung. Am J Pathol 154:909-918.
48. Thunnissen FB, Diegenbach PC, van Hattum AH, Tolboom J, van der Sluis DM, Schaafsma W, Houthoff HJ, Baak JP. 1992. Further evaluation of quantitative nuclear image features for classification of lung carcinomas. Pathol Res Pract 188:531-535.
49. Tomura A, Goto K, Morinaga H, Nomura M, Okabe T, Yanase T, Takayanagi R, Nawata H. 2001. The subnuclear three-dimensional image analysis of androgen receptor fused to green fluorescence protein. J Biol Chem 276:28395-28401.
50. True LD. 1988. Quantitative immunohistochemistry: A new tool for surgical pathology? Am J Clin Pathol 90:324-325.
51. True LD. 1996. Morphometric applications in anatomic pathology. Hum Pathol 27:450-467.
52. van Velthoven R, Petein M, Oosterlinck WJ, Roels H, Pasteels JL, Schulman C, Kiss R. 1995. The use of digital image analysis of chromatin texture in Feulgen-stained nuclei to predict recurrence of low-grade superficial transitional cell carcinoma of the bladder. Cancer 75:560-568.